-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cerevel Therapeutics Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- Cerevel Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $20.9M, a 66.2% increase year-over-year.
- Cerevel Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $77.8M, a 81.6% increase year-over-year.
- Cerevel Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $69.4M, a 79% increase from 2022.
- Cerevel Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $38.8M, a 62% increase from 2021.
- Cerevel Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $23.9M, a 128% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)